Showing 4241-4250 of 23240 results for "".
Utility of Coronary Angiography Before and After CABG
https://reachmd.com/programs/focus-on-heart-health/utility-of-coronary-angiography-before-and-after-cabg/4213/Cardiac surgery is one of just a few medical specialties where before-and-after imaging is not yet standard. As surprising as this may seem, the effect on procedural outcomes is not surprising: current strategies for intraoperative graft assessment, for example, are not detecting all of the defectsNotes From the 2009 ASCO Gastrointestinal Cancers Symposium
https://reachmd.com/programs/conference-coverage/notes-from-the-2009-asco-gastrointestinal-cancers-symposium/4178/Highlights of studies presented at the American Society of Clinical Oncology's 2009 Gastrointestinal Cancers Symposium, held January 15 through 17 in San Francisco.Highlights: 2008 San Antonio Breast Cancer Symposium
https://reachmd.com/programs/conference-coverage/highlights-2008-san-antonio-breast-cancer-symposium/4099/ReachMD brings you Conference Coverage Highlights from the 2008 San Antonio Breast Cancer Symposium, held December 10 through 14 in San Antonio, Texas. You will hear insights on the latest in research on breast cancer treatment and prevention.Aspirin Resistance and Its Implications in Clinical Practice
https://reachmd.com/programs/clinicians-roundtable/aspirin-resistance-and-its-implications-in-clinical-practice/3819/Recent studies indicate that some patients may not obtain the full benefits of aspirin's antiplatelet effects Guest Dr. Wayne Peters discusses with host Dr. Larry Kaskel the benefits of aspirin to prevent and manage heart disease, and the tests available to measure aspirin resistance or platelet funIn Pursuit of Success Against HIV
https://reachmd.com/programs/focus-on-public-health-policy/in-pursuit-of-success-against-hiv/3572/Dr. Anthony Fauci, director of National Institute of Allergy and Infectious Diseases at the National Institutes of Health discusses the sentiments and mood after the XVII International Conference on AIDS at Mexico City. He emphasizes the need for societies and individuals to implement effective andTeam Doc: Pressure from Players & Coaches
https://reachmd.com/programs/focus-on-sports-medicine/team-doc-pressure-from-players-coaches/3209/When a team's best player gets injured in the final minutes of a crucial playoff game, the most pivotal person in the stadium may be that team's lead physician. How does the responsibilities of a team physician change based on the specific injury, the player and the game situation? What are the respHow to Address Obesity in Clinical Practice
https://reachmd.com/programs/advances-in-womens-health/how-to-address-obesity-in-clinical-practice/3138/Host Dr. Lauren Streicher continues her discussion with Dr. Sandra Carson, professor of obstetrics and gynecology at the Warren Alpert Medical School at Brown University, on how to tackle the issue of treating obese women. They discuss diet plans, lifestyle modifications, counseling strategies, andAlcohol Use Disorders: Can We Do More?
https://reachmd.com/programs/clinicians-roundtable/alcohol-use-disorders-can-we-do-more/3068/Given the pervasiveness of alcohol use disorders (AUDs) in the United States, Dr. Mark Willenbring says, “we need to be intervening at a much earlier stage and providing treatment to a much broader range of people then we currently do.” Dr. Willenbring, director of the National Institute on AlcoholFinding & Developing Drugs for Rare Conditions
https://reachmd.com/programs/clinicians-roundtable/finding-developing-drugs-for-rare-conditions/3031/It seems most drug-makers are making their biggest sales to doctors by pushing medicines for common conditions whether they be statins for cholesterol or proton pump inhibitors for heartburn. But drugs can actually take on blockbuster significance for specialized treatment groups where treatment optThe Future of Oral Chemotherapeutic Agents
https://reachmd.com/programs/focus-on-pharmacy/the-future-of-oral-chemotherapeutic-agents/2693/What does the future hold for oral chemotherapeutic agents? Will they one day replace infusion therapies? Could they even transform cancer into a chronic, manageable disease treatable at home? Host Dr. Charles Turck speaks with Dr. Susan Goodin, Director of the Division of Pharmaceutical Sciences at